These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 33603076)

  • 1. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults.
    Xu R; Lu R; Zhang T; Wu Q; Cai W; Han X; Wan Z; Jin X; Zhang Z; Zhang C
    Commun Biol; 2021 Feb; 4(1):240. PubMed ID: 33603076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes.
    Hernández-Terán A; Mejía-Nepomuceno F; Herrera MT; Barreto O; García E; Castillejos M; Boukadida C; Matias-Florentino M; Rincón-Rubio A; Avila-Rios S; Mújica-Sánchez M; Serna-Muñoz R; Becerril-Vargas E; Guadarrama-Pérez C; Ahumada-Topete VH; Rodríguez-Llamazares S; Martínez-Orozco JA; Salas-Hernández J; Pérez-Padilla R; Vázquez-Pérez JA
    Sci Rep; 2021 Oct; 11(1):21297. PubMed ID: 34716394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19.
    Mazzarelli A; Giancola ML; Farina A; Marchioni L; Rueca M; Gruber CEM; Bartolini B; Ascoli Bartoli T; Maffongelli G; Capobianchi MR; Ippolito G; Di Caro A; Nicastri E; Pazienza V;
    PLoS One; 2021; 16(2):e0247041. PubMed ID: 33596245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.
    Xu R; Liu P; Zhang T; Wu Q; Zeng M; Ma Y; Jin X; Xu J; Zhang Z; Zhang C
    J Genet Genomics; 2021 Sep; 48(9):803-814. PubMed ID: 34238684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between gut microbiota dysbiosis and poor functional outcomes in acute ischemic stroke patients with COVID-19 infection.
    Chen J; Gao X; Liang J; Wu Q; Shen L; Zheng Y; Ma Y; Peng Y; He Y; Yin J
    mSystems; 2024 Jun; 9(6):e0018524. PubMed ID: 38700338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional profiling of COVID-19 respiratory tract microbiomes.
    Haiminen N; Utro F; Seabolt E; Parida L
    Sci Rep; 2021 Mar; 11(1):6433. PubMed ID: 33742096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota.
    Velmurugan G; Vasudevan D
    Biomed J; 2021 Aug; 44(4):504-507. PubMed ID: 34507920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
    Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
    Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General dynamics of the URT microbiome and microbial signs of recovery in COVID-19 patients.
    Ignatyeva O; Gostev V; Taraskina A; Tsvetkova I; Pavlova P; Sulian O; Ageevets V; Likholetova D; Chulkova P; Nikitina E; Matkava L; Terekhov M; Lisovaya D; Kashtanova D; Ivanov M; Kalinogorskaya O; Avdeeva A; Zhirkov A; Goleva O; Zakharenko S; Zhdanov K; Strizheletsky V; Gomon Y; Kruglov A; Ni O; Noskova T; Gorbova I; Cherenkova G; Shlyk I; Afanasyev A; Yudin V; Makarov V; Sidorenko S; Yudin S
    Benef Microbes; 2024 Feb; 15(2):145-164. PubMed ID: 38412868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of microbiome in the upper respiratory tract of COVID-19 patients.
    Zhang X; Nurxat N; Aili J; Yasen Y; Wang Q; Liu Q
    BMC Microbiol; 2024 Apr; 24(1):138. PubMed ID: 38658823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal multicompartment characterization of host-microbiota interactions in patients with acute respiratory failure.
    Kitsios GD; Sayed K; Fitch A; Yang H; Britton N; Shah F; Bain W; Evankovich JW; Qin S; Wang X; Li K; Patel A; Zhang Y; Radder J; Dela Cruz C; Okin DA; Huang CY; Van Tyne D; Benos PV; Methé B; Lai P; Morris A; McVerry BJ
    Nat Commun; 2024 Jun; 15(1):4708. PubMed ID: 38830853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
    Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X
    NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.